Bjornstad syndrome is a predominantly hair-and-hearing presentation of autosomal recessive BCS1L-related mitochondrial disease, characterized by pili torti, hair fragility and sensorineural hearing loss. Onset and hearing severity vary. BCS1L assists delivery of the folded Rieske iron-sulfur protein to respiratory complex III; pathogenic genotypes can impair assembly and alter cellular redox metabolism. The mechanisms determining cochlear and follicular vulnerability remain incompletely established. Most recognized cases have a restricted phenotype, but additional findings, including intellectual disability, have been reported. Severe multisystem BCS1L disorders overlap genetically and require a broader clinical assessment.
Ask a research question about Bjornstad Syndrome. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).
Do not include personal health information in your question. Questions and results are cached in your browser's local storage.
Conditions with similar clinical presentations that must be differentiated from Bjornstad Syndrome:
name: Bjornstad Syndrome
creation_date: "2026-09-03T00:00:00Z"
category: Mendelian
disease_term:
preferred_term: Bjornstad syndrome
term:
id: MONDO:0009872
label: Bjornstad syndrome
synonyms:
- Bjornstad syndrome
- Björnstad syndrome
- pili torti and nerve deafness
- pili torti-sensorineural hearing loss
- deafness and pili torti, Bjornstad type
- BJS
classifications:
mechanistic_category:
- classification_value: mitochondrial disease
notes: >-
BCS1L is a nuclear-encoded mitochondrial assembly factor. Predominantly hair and hearing manifestations
do not make this an mtDNA-inherited disorder.
evidence:
- reference: PMID:17314340
reference_title: Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
BCS1L encodes a member of the AAA family of ATPases that is necessary for
the assembly of complex III in the mitochondria.
explanation: >-
Identifies the causal gene as a mitochondrial respiratory chain assembly
factor, which is what places this disorder in the mitochondrial category.
quote_role: BACKGROUND
directness: DIRECT
description: >-
Bjornstad syndrome is a predominantly hair-and-hearing presentation of autosomal recessive BCS1L-related
mitochondrial disease, characterized by pili torti, hair fragility and sensorineural hearing loss. Onset
and hearing severity vary. BCS1L assists delivery of the folded Rieske iron-sulfur protein to respiratory
complex III; pathogenic genotypes can impair assembly and alter cellular redox metabolism. The mechanisms
determining cochlear and follicular vulnerability remain incompletely established. Most recognized cases
have a restricted phenotype, but additional findings, including intellectual disability, have been reported.
Severe multisystem BCS1L disorders overlap genetically and require a broader clinical assessment.
notes: >-
This entry centers on the pili-torti and hearing-loss phenotype, while distinguishing severe multisystem
BCS1L disease in the differential diagnosis. Published diagnostic labels overlap; an additional finding does
not by itself establish a separate molecular disorder. Gene and variant effects depend on the complete biallelic
genotype, and published protein numbering is retained as reported. The institutional PDF from the University
of Medicine and Pharmacy at Ho Chi Minh City is the full text of PMID:34931354, whose PubMed record lacks
an abstract. PMID:41466500 (late-onset alopecia) and PMID:41814923 (tofacitinib/minoxidil) are recent bibliographic
leads; the retrieved records contained no abstract and full text was not obtained, so no patient details
or treatment-response claims are derived from their titles.
inheritance:
- name: Autosomal recessive inheritance
inheritance_term:
preferred_term: Autosomal recessive inheritance
term:
id: HP:0000007
label: Autosomal recessive inheritance
expressivity: VARIABLE
penetrance: UNKNOWN
description: >-
Molecularly established BCS1L-related Bjornstad syndrome is autosomal recessive. Both homozygous and compound-heterozygous
genotypes occur, including a reported missense/nonsense combination. Protein residual function and clinical
severity cannot be inferred solely from the variant class. Historical apparently dominant pedigrees predated
identification of BCS1L and do not establish dominant BCS1L inheritance.
evidence:
- reference: PMID:17314340
reference_title: Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The Björnstad syndrome, an autosomal recessive disorder associated with
sensorineural hearing loss and pili torti, is caused by mutation of a
previously unidentified gene on chromosome 2q34-36.
explanation: >-
States the recessive mode of inheritance and the two defining clinical
features together.
quote_role: BACKGROUND
directness: DIRECT
- reference: PMID:24172246
reference_title: Novel mutation in AAA domain of BCS1L causing Bjornstad syndrome.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
A novel homozygous missense mutation c.901T>A was identified, which
segregated with the disease in the family.
explanation: >-
Homozygosity for a missense allele segregating with disease in a large
consanguineous family is direct evidence of recessive transmission.
quote_role: PRIMARY_RESULT
directness: DIRECT
- reference: PMID:25895478
reference_title: Exome sequencing reveals novel BCS1L mutations in siblings with hearing loss and hypotrichosis.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
The siblings were compound heterozygotes, and the inheritance mode of autosomal recessive was postulated.
explanation: >-
The molecular report documents a compound-heterozygous family.
quote_role: PRIMARY_RESULT
- reference: PMID:11807445
reference_title: 'Three members of a family with pili torti and sensorineural hearing loss: the Bjornstad syndrome.'
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: INDIRECT
snippet: >-
We describe a family in which 3 members have the combination of pili torti and varying degrees of hearing
loss inherited in an apparently autosomal dominant fashion.
explanation: >-
This pre-gene-discovery pedigree is a historical phenotypic observation, not evidence of a dominant BCS1L
allele.
quote_role: PRIMARY_RESULT
prevalence:
- population: Worldwide
measure_type: CASES_IN_LITERATURE
prevalence_class: UNKNOWN
notes: >-
Population prevalence is unknown. Published families and case reports do not supply a population denominator;
clinical ascertainment and molecular confirmation vary.
evidence:
- reference: PMID:24172246
reference_title: Novel mutation in AAA domain of BCS1L causing Bjornstad syndrome.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Only few large families have been reported worldwide.
explanation: >-
Describes sparse published pedigrees without quantifying population prevalence.
quote_role: BACKGROUND
directness: DIRECT
pathophysiology:
- name: BCS1L Rieske Protein Insertion Failure
biological_scale: MOLECULAR
description: >-
BCS1L is an inner-mitochondrial-membrane AAA ATPase that delivers the folded Rieske iron-sulfur protein,
UQCRFS1, during complex III maturation. Disease-associated genotypes impair this assembly function to varying
degrees. A Bjornstad-associated p.Arg183His protein retained partial UQCRFS1 binding in a HeLa-cell co-immunoprecipitation
assay. This supports impaired substrate engagement for that allele but does not directly measure insertion
kinetics. Neither normal ATP turnover nor an identical substrate-binding lesion has been established for
every Bjornstad genotype.
genes:
- preferred_term: BCS1L
term:
id: hgnc:1020
label: BCS1L
genetic_context:
gene:
preferred_term: BCS1L
term:
id: hgnc:1020
label: BCS1L
variant_origin: GERMLINE
functional_impact_category: PARTIAL_LOSS_OF_FUNCTION
description: >-
Biallelic pathogenic genotypes with variable residual BCS1L function; both homozygous and compound-heterozygous
states are reported, including a missense/nonsense pair. The molecular effect depends on the complete
genotype and cannot be assigned from variant class alone.
molecular_functions:
- preferred_term: BCS1L-mediated translocation of folded Rieske protein
term:
id: GO:0008320
label: transmembrane protein transporter activity
biological_processes:
- preferred_term: insertion of the Rieske iron-sulfur protein into the inner membrane
modifier: DECREASED
term:
id: GO:0045039
label: protein insertion into mitochondrial inner membrane
evidence:
- reference: PMID:40660675
reference_title: "BCS1L-Associated Disease: 5'-UTR Variant Shifts the Phenotype Towards Axonal Neuropathy."
supports: SUPPORT
evidence_source: IN_VITRO
directness: DIRECT
snippet: >-
Co‐immunoprecipitation assays showed that p.L280F exhibited markedly reduced interaction with UQCRFS1,
similar to the severe GRACILE‐associated S78G variant, whereas p.R183H retained partial binding (Figure
3G).
explanation: >-
The HeLa-cell assay includes a Bjornstad-associated comparator, p.Arg183His. It measures protein association,
not ATPase turnover or translocation rate.
quote_role: PRIMARY_RESULT
- reference: PMID:38821922
reference_title: Conformations of Bcs1L undergoing ATP hydrolysis suggest a concerted translocation mechanism for folded iron-sulfur protein substrate.
supports: SUPPORT
evidence_source: IN_VITRO
directness: INDIRECT
snippet: >-
Our results show that Bcs1L transitions directly between the ATP and ADP conformations, with no indication
of the existence of additional intermediate forms, supporting a concerted mechanism.
explanation: >-
Purified wild-type mouse Bcs1L with a bovine Rieske extrinsic-domain substrate informs normal transport
architecture. It does not establish the molecular defect of a human Bjornstad allele.
quote_role: PRIMARY_RESULT
downstream:
- target: Complex III Assembly Defect
description: >-
Impaired Rieske delivery compromises complex III maturation.
causal_link_type: DIRECT
evidence:
- reference: PMID:17314340
reference_title: Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome.
supports: SUPPORT
evidence_source: IN_VITRO
directness: DIRECT
snippet: >-
All mutant BCS1L proteins disrupted the assembly of complex III, reduced the activity of the mitochondrial
electron-transport chain, and increased the production of reactive oxygen species.
explanation: >-
The functional study reports assembly, respiratory and ROS abnormalities for the tested mutant set.
Its cell-based biochemical findings should not be generalized to every subsequently reported allele.
quote_role: PRIMARY_RESULT
- name: Complex III Assembly Defect
description: >-
BCS1L dysfunction compromises maturation of Rieske-containing complex III and respiratory supercomplex
organization. The extent of the assembly abnormality depends on the genotype and assay system; complete
absence of mature complex III is not established across Bjornstad cases.
biological_scale: MOLECULAR
evidence:
- reference: PMID:17314340
reference_title: Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome.
supports: SUPPORT
evidence_source: IN_VITRO
directness: DIRECT
snippet: >-
All mutant BCS1L proteins disrupted the assembly of complex III, reduced the activity of the mitochondrial
electron-transport chain, and increased the production of reactive oxygen species.
explanation: >-
The functional study reports assembly, respiratory and ROS abnormalities for the tested mutant set. Its
cell-based biochemical findings should not be generalized to every subsequently reported allele.
quote_role: PRIMARY_RESULT
downstream:
- target: Reduced respiratory electron transfer
description: >-
Reduced assembly of catalytically competent complex III impairs electron transport.
causal_link_type: DIRECT
evidence:
- reference: PMID:17314340
reference_title: Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome.
supports: SUPPORT
evidence_source: IN_VITRO
directness: DIRECT
snippet: >-
All mutant BCS1L proteins disrupted the assembly of complex III, reduced the activity of the mitochondrial
electron-transport chain, and increased the production of reactive oxygen species.
explanation: >-
The functional study reports assembly, respiratory and ROS abnormalities for the tested mutant set.
Its cell-based biochemical findings should not be generalized to every subsequently reported allele.
quote_role: PRIMARY_RESULT
biological_processes:
- preferred_term: mitochondrial respiratory chain complex III assembly
term:
id: GO:0034551
label: mitochondrial respiratory chain complex III assembly
modifier: DECREASED
- name: Reduced respiratory electron transfer
description: >-
Reduced mitochondrial electron-transfer activity was measured in the original functional study of BCS1L
mutants. This is a biochemical consequence distinct from the assembly defect and is not a claim that every
patient has abnormal muscle respiratory-enzyme testing.
biological_scale: MOLECULAR
evidence:
- reference: PMID:17314340
reference_title: Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome.
supports: SUPPORT
evidence_source: IN_VITRO
directness: DIRECT
snippet: >-
All mutant BCS1L proteins disrupted the assembly of complex III, reduced the activity of the mitochondrial
electron-transport chain, and increased the production of reactive oxygen species.
explanation: >-
The functional study reports assembly, respiratory and ROS abnormalities for the tested mutant set. Its
cell-based biochemical findings should not be generalized to every subsequently reported allele.
quote_role: PRIMARY_RESULT
downstream:
- target: Excess Reactive Oxygen Species Production
description: >-
Respiratory dysfunction is associated with increased cellular ROS in the functional study; the intervening
source-specific redox mechanisms are not fully resolved.
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
evidence:
- reference: PMID:17314340
reference_title: Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome.
supports: SUPPORT
evidence_source: IN_VITRO
directness: INDIRECT
snippet: >-
All mutant BCS1L proteins disrupted the assembly of complex III, reduced the activity of the mitochondrial
electron-transport chain, and increased the production of reactive oxygen species.
explanation: >-
The functional study reports assembly, respiratory and ROS abnormalities for the tested mutant set.
Its cell-based biochemical findings should not be generalized to every subsequently reported allele.
quote_role: PRIMARY_RESULT
biological_processes:
- preferred_term: respiratory electron transport chain
term:
id: GO:0022904
label: respiratory electron transport chain
modifier: DECREASED
- name: Excess Reactive Oxygen Species Production
biological_scale: CELLULAR
description: >-
The original functional study found increased cellular reactive oxygen species for its tested BCS1L mutants.
Only the severe complex-III-deficiency mutant group also showed increased mitochondrial content in that
comparison. These results support disturbed cellular redox metabolism but do not identify incompletely
assembled complex III as the source of increased superoxide or establish a universal quantitative severity
rule. Selective tissue injury is a further hypothesis.
biological_processes:
- preferred_term: reactive oxygen species metabolic process
modifier: INCREASED
term:
id: GO:0072593
label: reactive oxygen species metabolic process
evidence:
- reference: PMID:17314340
reference_title: Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome.
supports: SUPPORT
evidence_source: IN_VITRO
directness: DIRECT
snippet: >-
All mutant BCS1L proteins disrupted the assembly of complex III, reduced the activity of the mitochondrial
electron-transport chain, and increased the production of reactive oxygen species.
explanation: >-
The functional study reports assembly, respiratory and ROS abnormalities for the tested mutant set. Its
cell-based biochemical findings should not be generalized to every subsequently reported allele.
quote_role: PRIMARY_RESULT
- reference: PMID:17314340
reference_title: Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome.
supports: SUPPORT
evidence_source: IN_VITRO
snippet: >-
However, only mutations associated with complex III deficiency increased
mitochondrial content, which further increased the production of reactive
oxygen species.
explanation: >-
The measured mitochondrial-content difference applies to the groups tested in this study; it does not
by itself explain all tissue selectivity or all later genotypes.
quote_role: PRIMARY_RESULT
directness: DIRECT
downstream:
- target: Cochlear Oxidative Injury
description: >-
Increased cellular ROS is proposed to produce preferential cochlear injury.
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
evidence:
- reference: PMID:17314340
reference_title: Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome.
supports: SUPPORT
evidence_source: OTHER
directness: INDIRECT
snippet: >-
Mutations that cause the Björnstad syndrome illustrate the exquisite sensitivity of ear and hair tissues
to mitochondrial function, particularly to the production of reactive oxygen species.
explanation: >-
This is the authors' mechanistic interpretation of the clinical and biochemical findings, not a direct
tissue-specific oxidative-injury experiment.
quote_role: PRIMARY_RESULT
hypothesis_groups:
- ROS_TISSUE_VULNERABILITY
- target: Hair Shaft Keratin Assembly Failure
description: >-
ROS is proposed to contribute to abnormal follicular keratin organization, but this was not measured
in the ultrastructural study.
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
evidence:
- reference: PMID:17314340
reference_title: Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome.
supports: SUPPORT
evidence_source: OTHER
directness: INDIRECT
snippet: >-
Mutations that cause the Björnstad syndrome illustrate the exquisite sensitivity of ear and hair tissues
to mitochondrial function, particularly to the production of reactive oxygen species.
explanation: >-
This is the authors' mechanistic interpretation of the clinical and biochemical findings, not a direct
tissue-specific oxidative-injury experiment.
quote_role: PRIMARY_RESULT
hypothesis_groups:
- ROS_TISSUE_VULNERABILITY
- name: Cochlear Oxidative Injury
biological_scale: TISSUE
conforms_to: sensorineural_hair_cell_loss#Cochlear Ionic Homeostasis Disruption and Oxidative Stress
description: >-
Oxidative injury is a proposed connection between disturbed mitochondrial function and the cochlear hearing
phenotype. The reviewed studies do not directly demonstrate elevated ROS or hair-cell death in Bjornstad
cochlear tissue. The annotated hair-cell types are candidate affected cells, not a reported histological
finding. Relative vulnerability, energy supply and structural cochlear abnormalities require separate evaluation;
a specific defect in potassium recycling is not established.
cell_types:
- preferred_term: cochlear inner hair cell
term:
id: CL:0000589
label: cochlear inner hair cell
- preferred_term: cochlear outer hair cell
term:
id: CL:0000601
label: cochlear outer hair cell
biological_processes:
- preferred_term: response to oxidative stress
term:
id: GO:0006979
label: response to oxidative stress
modifier: ABNORMAL
evidence:
- reference: PMID:17314340
reference_title: Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome.
supports: SUPPORT
evidence_source: OTHER
directness: INDIRECT
snippet: >-
Mutations that cause the Björnstad syndrome illustrate the exquisite sensitivity of ear and hair tissues
to mitochondrial function, particularly to the production of reactive oxygen species.
explanation: >-
This is the authors' mechanistic interpretation of the clinical and biochemical findings, not a direct
tissue-specific oxidative-injury experiment.
quote_role: PRIMARY_RESULT
downstream:
- target: Sensorineural hearing impairment
description: >-
Oxidative injury is hypothesized to impair cochlear function; the specific cellular route to hearing
loss remains unproven.
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
evidence:
- reference: PMID:17314340
reference_title: Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome.
supports: SUPPORT
evidence_source: OTHER
directness: INDIRECT
snippet: >-
Mutations that cause the Björnstad syndrome illustrate the exquisite sensitivity of ear and hair tissues
to mitochondrial function, particularly to the production of reactive oxygen species.
explanation: >-
This is the authors' mechanistic interpretation of the clinical and biochemical findings, not a direct
tissue-specific oxidative-injury experiment.
quote_role: PRIMARY_RESULT
hypothesis_groups:
- ROS_TISSUE_VULNERABILITY
- name: Hair Shaft Keratin Assembly Failure
biological_scale: TISSUE
description: >-
Transmission electron microscopy in one Bjornstad patient showed wavy cuticle layers of variable thickness
and loosely packed cortical keratin intermediate filaments. The authors localized the abnormalities below
the infundibulum and proposed abnormal disulfide bonding; they did not directly measure a disulfide-bond
defect or establish ROS as its cause. Ex vivo hair testing found reduced mechanical strength, consistent
with the fragile, twisted shaft phenotype.
cell_types:
- preferred_term: hair follicular keratinocyte
term:
id: CL:2000092
label: hair follicular keratinocyte
evidence:
- reference: PMID:27882597
reference_title: Morphological analyses in fragility of pili torti with Björnstad syndrome.
supports: SUPPORT
evidence_source: IN_VITRO
snippet: >-
Additionally, the cortex in the samples showed loose keratin intermediate
filaments (IF).
explanation: >-
Reports the ultrastructural cortical abnormality underlying the fragile
shaft in a Bjornstad patient's hair.
quote_role: PRIMARY_RESULT
directness: DIRECT
- reference: PMID:27882597
reference_title: Morphological analyses in fragility of pili torti with Björnstad syndrome.
supports: SUPPORT
evidence_source: IN_VITRO
snippet: >-
Our results suggested that these abnormalities in pili torti had already
occurred below the infundibulum.
explanation: >-
Places the lesion inside the follicle during keratinization rather than in
the emerged shaft, which is what makes it a follicular rather than a
cosmetic problem.
quote_role: PRIMARY_RESULT
directness: DIRECT
downstream:
- target: Pili torti
description: >-
Abnormal shaft organization and fragility contribute to this hair phenotype; the intervening relationship
is inferred from morphology and clinical observation.
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
evidence:
- reference: PMID:24172246
reference_title: Novel mutation in AAA domain of BCS1L causing Bjornstad syndrome.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The hair fibers of all the patients were twisted around their axis and
devoid of any pigment.
explanation: >-
Five affected members of one family, all with twisted hair fibers,
documenting the phenotype within a single kindred.
quote_role: PRIMARY_RESULT
directness: INDIRECT
- target: Brittle hair
description: >-
Abnormal shaft organization and fragility contribute to this hair phenotype; the intervening relationship
is inferred from morphology and clinical observation.
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
evidence:
- reference: PMID:32395403
reference_title: Ketogenic diet for treating alopecia in BCS1l-related mitochondrial disease (Bjornstad syndrome).
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
with very sparse and brittle hair since birth
explanation: >-
Records sparse, brittle hair present from birth in a genetically confirmed
patient.
quote_role: PRIMARY_RESULT
directness: INDIRECT
- target: Sparse scalp hair
description: >-
Abnormal shaft organization and fragility contribute to this hair phenotype; the intervening relationship
is inferred from morphology and clinical observation.
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
evidence:
- reference: PMID:32395403
reference_title: Ketogenic diet for treating alopecia in BCS1l-related mitochondrial disease (Bjornstad syndrome).
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: INDIRECT
snippet: >-
with very sparse and brittle hair since birth
explanation: >-
This directly documents reduced scalp hair density in the reported patient.
quote_role: PRIMARY_RESULT
phenotypes:
- name: Pili torti
category: Integumentary
description: >-
Flattened hair shafts twist around their long axis. Scalp hair is usually most affected, but other hair
findings vary between reports. Pili torti is a defining sign in combination with hearing loss and is not
specific to this syndrome alone.
phenotype_term:
preferred_term: Pili torti
term:
id: HP:0003777
label: Pili torti
evidence:
- reference: PMID:28322498
reference_title: Novel compound heterozygous mutations in BCS1L gene causing Bjornstad syndrome in two siblings.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Bjornstad syndrome is a rare condition characterized by pili torti and
sensorineural hearing loss associated with pathological variations in
BCS1L.
explanation: >-
The introduction identifies pili torti as a conventional defining feature; it does not estimate its population
frequency.
quote_role: BACKGROUND
directness: DIRECT
- reference: PMID:24172246
reference_title: Novel mutation in AAA domain of BCS1L causing Bjornstad syndrome.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The hair fibers of all the patients were twisted around their axis and
devoid of any pigment.
explanation: >-
Five affected members of one family, all with twisted hair fibers,
documenting the phenotype within a single kindred.
quote_role: PRIMARY_RESULT
directness: DIRECT
notes: >-
A defining component of the conventional clinical diagnosis; available selected reports do not establish
population penetrance or a quantitative frequency band.
- name: Sensorineural hearing impairment
category: Auditory
description: >-
Sensorineural hearing loss ranges from moderate to profound and is commonly recognized in infancy or childhood.
Progression is documented in individual patients, but a uniform progressive course is not established.
Early hearing assessment and communication support address its developmental impact.
phenotype_term:
preferred_term: Sensorineural hearing impairment
term:
id: HP:0000407
label: Sensorineural hearing impairment
onset:
onset_category: CHILDHOOD
notes: Hearing loss was noted from 18 months in the 2020 case, within the HPO childhood interval; onset varies between patients.
evidence:
- reference: PMID:24172246
reference_title: Novel mutation in AAA domain of BCS1L causing Bjornstad syndrome.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
In addition the patients had a moderate-to-severe degree of hearing
impairment.
explanation: >-
Documents the severity range of the hearing loss in all five affected
members of one family.
quote_role: PRIMARY_RESULT
directness: DIRECT
- reference: PMID:30582773
reference_title: Clinical spectrum of BCS1L Mitopathies and their underlying structural relationships.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Disease phenotypes are varied and can be as mild as Björnstad syndrome,
characterized by pili torti and sensorineural hearing loss, or as severe as
GRACILE syndrome, characterized by growth restriction, aminoaciduria,
cholestasis, iron overload, lactic acidosis, and early death.
explanation: >-
A review of all published BCS1L patients confirms sensorineural hearing
loss as one of the two defining Bjornstad features.
quote_role: REVIEW_SYNTHESIS
directness: DIRECT
- reference: PMID:32395403
reference_title: Ketogenic diet for treating alopecia in BCS1l-related mitochondrial disease (Bjornstad syndrome).
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
with progressive sensori‐neural hearing loss noted from age 18 months onwards.
explanation: >-
The individual case supports possible progression and early onset, not a universal course.
quote_role: PRIMARY_RESULT
notes: >-
A defining component of the conventional clinical diagnosis; available selected reports do not establish
population penetrance or a quantitative frequency band.
- name: Brittle hair
category: Integumentary
description: >-
Hair shafts can be thin, brittle and easily broken, contributing to sparse or short scalp hair. Fragility
was present from birth in the ketogenic-diet case report.
phenotype_term:
preferred_term: Brittle hair
term:
id: HP:0002299
label: Brittle hair
evidence:
- reference: PMID:32395403
reference_title: Ketogenic diet for treating alopecia in BCS1l-related mitochondrial disease (Bjornstad syndrome).
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
with very sparse and brittle hair since birth
explanation: >-
Records sparse, brittle hair present from birth in a genetically confirmed
patient.
quote_role: PRIMARY_RESULT
directness: DIRECT
notes: >-
Hair fragility is documented clinically and by ex vivo mechanical testing; no population frequency is assigned.
- name: Incomplete partition of the cochlea type I
category: Auditory
description: >-
Bilateral incomplete partition type I was reported in two siblings with profound hearing loss undergoing
cochlear implantation. This structural malformation requires consideration in surgical assessment; the
report does not establish its population frequency or a link to oxidative injury.
phenotype_term:
preferred_term: Incomplete partition of the cochlea type I
term:
id: HP:0011374
label: Incomplete partition of the cochlea type I
laterality: BILATERAL
evidence:
- reference: PMID:37816838
reference_title: "Cochlear implantation in Bjornstad syndrome: a case series with literature review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Cochlear implant surgeries of two siblings (four ears) with profound SNHL
and bilateral inner ear anomaly (incomplete partition type 1) were
performed without complications.
explanation: >-
Documents the malformation in both affected siblings, bilaterally, on
preoperative assessment.
quote_role: PRIMARY_RESULT
directness: DIRECT
notes: >-
The evidence is one ascertained family. Its association with BCS1L disease and developmental mechanism
remain uncertain, so no specific causal path is assigned.
- name: Sparse scalp hair
description: >-
Sparse scalp hair may reflect shaft fragility and hair loss. It was present from birth in one molecularly
diagnosed patient.
phenotype_term:
preferred_term: Sparse scalp hair
term:
id: HP:0002209
label: Sparse scalp hair
evidence:
- reference: PMID:32395403
reference_title: Ketogenic diet for treating alopecia in BCS1l-related mitochondrial disease (Bjornstad syndrome).
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
with very sparse and brittle hair since birth
explanation: >-
This directly documents reduced scalp hair density in the reported patient.
quote_role: PRIMARY_RESULT
category: Integumentary
- name: Intellectual disability
description: >-
Intellectual disability was recorded on developmental assessment in a six-year-old with molecularly diagnosed
Bjornstad syndrome. It is not a defining feature; frequency, contribution of hearing impairment and the
specific mechanism remain unresolved.
phenotype_term:
preferred_term: Intellectual disability
term:
id: HP:0001249
label: Intellectual disability
evidence:
- reference: url:https://cmb.ump.edu.vn/upload/userfiles/images/B%C3%80I%20B%C3%81O/2021_Alopecia%20and%20hearing%20loss%20in%20a%20boy.pdf
reference_title: https://cmb.ump.edu.vn/upload/userfiles/images/B%C3%80I%20B%C3%81O/2021_Alopecia%20and%20hearing%20loss%20in%20a%20boy.pdf
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
Developmental assessment showed intellectual disability.
explanation: >-
The case report directly records this additional manifestation; it does not justify attributing every
developmental difficulty solely to hearing loss.
quote_role: PRIMARY_RESULT
category: Neurodevelopmental
genetic:
- name: BCS1L
gene_term:
preferred_term: BCS1L
term:
id: hgnc:1020
label: BCS1L
relationship_type: CAUSATIVE
variant_origin: GERMLINE
notes: >-
Reported genotypes include homozygous missense variants, compound missense variants, and a missense/nonsense
pair. The 2007 structural model distinguished the variants then studied, but it does not establish one
residue class, unaffected ATP turnover, or a deterministic severity rule for every Bjornstad genotype.
Variant names below follow their source transcripts; segregation and functional findings are distinguished
from computational predictions.
variants:
- name: NM_001079866.1:c.901T>A (p.Tyr301Asn)
type: MISSENSE
description: >-
Homozygous AAA-domain missense allele segregating with Bjornstad syndrome
in a large consanguineous Pakistani family with five affected individuals.
evidence:
- reference: PMID:24172246
reference_title: Novel mutation in AAA domain of BCS1L causing Bjornstad syndrome.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
A novel homozygous missense mutation c.901T>A was identified, which
segregated with the disease in the family.
explanation: >-
Homozygosity for a missense allele segregating with disease in a large
consanguineous family is direct evidence of recessive transmission.
quote_role: PRIMARY_RESULT
directness: DIRECT
- name: p.Arg306Cys / p.Arg186Ter, as reported
description: >-
Compound missense/nonsense genotype reported in two siblings diagnosed with Bjornstad syndrome; this
disproves restriction to pairs of missense variants.
evidence:
- reference: PMID:25895478
reference_title: Exome sequencing reveals novel BCS1L mutations in siblings with hearing loss and hypotrichosis.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
By analysis of exome of the proband, we identified a novel missense (p.R306C) mutation and a nonsense
(p.R186*) mutation in the BCS1L gene.
explanation: >-
Both variant classes were identified and subsequently confirmed by Sanger sequencing in the report.
quote_role: PRIMARY_RESULT
- name: c.232A>G (p.Ser78Gly) / c.794G>A (p.Arg265Gln), NM_001079866.2
description: >-
Compound genotype in the diet case report. The Ser78Gly allele is also associated with severe disease
in other genotypic contexts; its presence alone does not determine the phenotype.
evidence:
- reference: PMID:32395403
reference_title: Ketogenic diet for treating alopecia in BCS1l-related mitochondrial disease (Bjornstad syndrome).
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
We report on a 7‐year‐old female (BCS1L, NM_001079866.2, c.232A>G; p.Ser78Gly, c.794G>A; p.Arg265Gln)
explanation: >-
The source supplies the transcript and both alleles of the reported genotype.
quote_role: PRIMARY_RESULT
- name: c.649G>C (p.Asp217His) / c.671G>A (p.Arg224His), as reported
description: >-
Two missense variants segregated from opposite unaffected parents in the 2021 case. Their specific biochemical
effects were hypothesized rather than measured.
evidence:
- reference: url:https://cmb.ump.edu.vn/upload/userfiles/images/B%C3%80I%20B%C3%81O/2021_Alopecia%20and%20hearing%20loss%20in%20a%20boy.pdf
reference_title: https://cmb.ump.edu.vn/upload/userfiles/images/B%C3%80I%20B%C3%81O/2021_Alopecia%20and%20hearing%20loss%20in%20a%20boy.pdf
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
Further investigation revealed that the patient's unaffected mother carried the heterozygous variant
in exon 4 (c.649G >C; p. Asp217His), while his unaffected father had the heterozygous variant in exon
5 (c.671G >A; p. Arg224His).
explanation: >-
The full report documents parental segregation, with maternal Asp217His and paternal Arg224His; neither
parent had the hair/hearing phenotype.
quote_role: PRIMARY_RESULT
evidence:
- reference: PMID:17314340
reference_title: Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Refined genetic mapping and DNA sequencing of 44 genes between D2S2210 and
D2S2244 revealed BCS1L mutations.
explanation: >-
The gene-identification study that established BCS1L as the Bjornstad
syndrome locus.
quote_role: PRIMARY_RESULT
directness: DIRECT
- reference: PMID:24172246
reference_title: Novel mutation in AAA domain of BCS1L causing Bjornstad syndrome.
supports: SUPPORT
evidence_source: COMPUTATIONAL
snippet: >-
This mutation results in the amino acid change p.Tyr301Asn and was
predicted to be pathogenic by bioinformatics tools.
explanation: >-
The amino-acid change is reported, but the quoted pathogenicity assessment is computational prediction,
not a biochemical assay.
quote_role: PRIMARY_RESULT
directness: DIRECT
diagnosis:
- name: Hair-shaft microscopy
description: >-
Microscopic assessment identifies flattened and twisted hair shafts; electron microscopy documented these
changes in the cited case. Hair findings need interpretation with audiology and molecular testing because
pili torti occurs in multiple inherited and acquired conditions.
evidence:
- reference: url:https://cmb.ump.edu.vn/upload/userfiles/images/B%C3%80I%20B%C3%81O/2021_Alopecia%20and%20hearing%20loss%20in%20a%20boy.pdf
reference_title: https://cmb.ump.edu.vn/upload/userfiles/images/B%C3%80I%20B%C3%81O/2021_Alopecia%20and%20hearing%20loss%20in%20a%20boy.pdf
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
Electron microscopy of hairs revealed flattening and twisting around the long axis.
explanation: >-
Directly documents diagnostic hair microscopy.
quote_role: PRIMARY_RESULT
- name: BCS1L sequencing
description: >-
BCS1L sequencing with parental segregation can confirm a compatible recessive genotype; exome or broader
hearing-loss testing can help in atypical presentations. Normal muscle respiratory-chain enzyme activities
do not exclude BCS1L disease: this limitation was observed in intermediate and severe cases, rather than
demonstrated to be specific to classic Bjornstad syndrome.
evidence:
- reference: PMID:31435670
reference_title: Molecular genetic investigations identify new clinical phenotypes associated with BCS1L-related mitochondrial disease.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
biochemical analysis of Complex III revealed normal respiratory chain
enzyme activities in the muscle of both patients
explanation: >-
The two tested patients had intermediate multisystem disease and GRACILE syndrome. Their normal muscle
enzyme assays establish a broader diagnostic limitation, not a finding unique to mild Bjornstad disease.
directness: INDIRECT
quote_role: PRIMARY_RESULT
- reference: PMID:25895478
reference_title: Exome sequencing reveals novel BCS1L mutations in siblings with hearing loss and hypotrichosis.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
Our study extends the phenotypic spectrum of Björnstad syndrome and highlights the clinical applicability
of exome sequencing as a diagnostic tool for atypical Mendelian disorders.
explanation: >-
The report supports molecular investigation of atypical hearing and hair presentations.
quote_role: PRIMARY_RESULT
- name: Audiologic assessment and inner-ear imaging
description: >-
Audiologic testing defines hearing severity and response to hearing aids. Imaging is important during cochlear-implant
assessment because bilateral incomplete partition type I occurred in the reported implanted siblings.
evidence:
- reference: PMID:37816838
reference_title: "Cochlear implantation in Bjornstad syndrome: a case series with literature review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Cochlear implant surgeries of two siblings (four ears) with profound SNHL
and bilateral inner ear anomaly (incomplete partition type 1) were
performed without complications.
explanation: >-
Documents the malformation in both affected siblings, bilaterally, on
preoperative assessment.
quote_role: PRIMARY_RESULT
directness: DIRECT
differential_diagnoses:
- name: GRACILE syndrome
description: >-
A severe allelic BCS1L disorder with fetal growth restriction, aminoaciduria, cholestasis, iron overload,
lactic acidosis and early death. Clinical severity and organ involvement depend on the complete genotype;
a single residue-class rule does not reliably distinguish the syndromes.
evidence:
- reference: PMID:17314340
reference_title: Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
BCS1L mutations cause disease phenotypes ranging from highly restricted
pili torti and sensorineural hearing loss (the Björnstad syndrome) to
profound multisystem organ failure (complex III deficiency and the GRACILE
syndrome).
explanation: >-
States the allelic relationship and the clinical distance between the two
ends of the BCS1L spectrum.
quote_role: PRIMARY_RESULT
directness: DIRECT
- name: BCS1L-related complex III deficiency
description: >-
Broader BCS1L disease can involve renal tubulopathy, hepatic dysfunction, encephalopathy, seizures or neuropathy.
Biochemical complex III impairment is variably detected across tissues. These multisystem presentations
should not automatically be assigned to the predominantly hair-and-hearing phenotype.
evidence:
- reference: PMID:22991165
reference_title: Clinical and biochemical features associated with BCS1L mutation.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
All affected members of the families have an identical mutation in this
gene, mutations of which are recognized causes of Björnstad syndrome,
GRACILE syndrome and a syndrome of neonatal tubulopathy, encephalopathy,
and liver failure (MIM 606104) leading to isolated mitochondrial
respiratory chain complex III deficiency.
explanation: >-
Enumerates the allelic BCS1L disorders that must be distinguished from the
restricted Bjornstad phenotype.
quote_role: BACKGROUND
directness: DIRECT
- name: BCS1L Mitopathies (intermediate phenotypes)
description: >-
A proposed name for intermediate BCS1L phenotypes with variable renal, hepatic, neurologic and growth manifestations.
Published labels overlap; assessment should characterize the organ findings and complete genotype rather
than rely on the syndrome name alone.
evidence:
- reference: PMID:30582773
reference_title: Clinical spectrum of BCS1L Mitopathies and their underlying structural relationships.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
We propose a change in nomenclature that unifies the intermediate
phenotype under "BCS1L Mitopathies".
explanation: >-
Records the proposed intermediate category so that entries between the two
poles are not forced into the Bjornstad label.
quote_role: PRIMARY_RESULT
directness: DIRECT
- name: Menkes disease
description: >-
An X-linked copper transport disorder (ATP7A) that also produces pili torti,
but with progressive neurodegeneration, seizures, hypotonia and connective
tissue laxity from infancy, and with low serum copper and ceruloplasmin.
Considered because pili torti on hair microscopy is the shared finding.
evidence:
- reference: PMID:34501349
reference_title: 'Pili Torti: A Feature of Numerous Congenital and Acquired Conditions.'
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
In patients with Menkes disease, neurodegenerative signs, including seizures, feeding difficulties, hypotonia,
and psychomotor retardation usually occur at 2–3 months of age [5].
explanation: >-
The review contrasts early neurologic disease with the predominantly hair-and-hearing presentation.
quote_role: REVIEW_SYNTHESIS
- name: Bazex-Dupre-Christol syndrome
description: >-
An X-linked disorder characterized by follicular atrophoderma, hypotrichosis, milia and early basal cell
carcinomas. Pili torti may overlap, while the cutaneous tumour predisposition and follicular atrophoderma
distinguish its usual presentation.
evidence:
- reference: PMID:34501349
reference_title: 'Pili Torti: A Feature of Numerous Congenital and Acquired Conditions.'
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
Bazex-Dupré-Christol syndrome is an X-linked semidominant disorder characterized by follicular atrophoderma,
multiple milia, hypotrichosis, hypohidrosis, and an early development of basal cell carcinomas [54,55].
explanation: >-
The review supplies the distinguishing cutaneous phenotype. Its gene attribution is not adopted here.
quote_role: REVIEW_SYNTHESIS
- name: Crandall syndrome
description: >-
Pili torti and sensorineural hearing loss can overlap, while hypogonadism distinguishes the reported Crandall
phenotype.
evidence:
- reference: url:https://cmb.ump.edu.vn/upload/userfiles/images/B%C3%80I%20B%C3%81O/2021_Alopecia%20and%20hearing%20loss%20in%20a%20boy.pdf
reference_title: https://cmb.ump.edu.vn/upload/userfiles/images/B%C3%80I%20B%C3%81O/2021_Alopecia%20and%20hearing%20loss%20in%20a%20boy.pdf
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
While pili torti and sensorineural hearing loss have been described in both Bjornstad syndrome and Crandall's
syndrome, the latter is differentiated by hypogonadism.
explanation: >-
The discussion identifies the shared features and clinical distinction.
quote_role: BACKGROUND
treatments:
- name: Cochlear implantation for profound hearing loss
description: >-
Bilateral cochlear implantation was reported in two siblings with profound sensorineural hearing loss unresponsive
to conventional hearing aids. Surgery was completed without observed complications and postoperative audiometry
improved. The small family report supports considering implantation under usual candidacy assessment, not
a syndrome-wide safety or efficacy estimate.
therapeutic_modality: SURGERY
treatment_term:
preferred_term: cochlear implant placement
term:
id: NCIT:C15329
label: Surgical Procedure
qualifiers:
- predicate:
preferred_term: medical device
term:
id: NCIT:C16830
label: Medical Device
value:
preferred_term: cochlear implant
term:
id: NCIT:C157820
label: Cochlear Implant
evidence:
- reference: PMID:37816838
reference_title: "Cochlear implantation in Bjornstad syndrome: a case series with literature review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
A retrospective report of two siblings with Bjornstad syndrome suffering
profound SNHL unresponsive to conventional hearing aids treated with
bilateral simultaneous cochlear implantation.
explanation: >-
Documents the small retrospective family report and its indication.
quote_role: PRIMARY_RESULT
directness: DIRECT
- reference: PMID:37816838
reference_title: 'Cochlear implantation in Bjornstad syndrome: a case series with literature review.'
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
Postoperative audiometric measurements showed a significiant improvement in pure-tone threshold and a
word recognition score.
explanation: >-
The two-sibling report documents improvement; it does not establish a population-level efficacy estimate.
quote_role: PRIMARY_RESULT
notes: >-
The evidence comprises two siblings with four implanted ears and bilateral incomplete partition type I.
Anatomical and audiologic evaluation remain necessary; treatment outcomes cannot be generalized from this
family.
target_phenotypes:
- preferred_term: Sensorineural hearing impairment
term:
id: HP:0000407
label: Sensorineural hearing impairment
- name: Modified Atkins (mild ketogenic) diet
description: >-
A modified Atkins diet was used for four months in one seven-year-old with a reported Bjornstad genotype.
Hair growth improved and was lost again after the diet stopped; hearing did not improve. There was no control
group or measured correction of oxidative stress. Aminoaciduria was neither confirmed nor excluded, leaving
a potential additional contributor to hair loss.
therapeutic_modality: BEHAVIORAL
treatment_term:
preferred_term: mild ketogenic (modified Atkins) diet
term:
id: NCIT:C15447
label: Dietary Intervention
target_mechanisms:
- target: Excess Reactive Oxygen Species Production
description: >-
Reduced oxidative stress is a proposed rationale from general ketogenic-diet literature; the patient
report did not measure this mechanism.
evidence:
- reference: PMID:32395403
reference_title: Ketogenic diet for treating alopecia in BCS1l-related mitochondrial disease (Bjornstad syndrome).
supports: SUPPORT
directness: INDIRECT
evidence_source: OTHER
snippet: >-
Ketogenic diets stimulate mitochondrial biogenesis, improve mitochondrial
function and decrease oxidative stress
explanation: >-
States the proposed mechanism of action against the oxidative-stress
node; the inference from general ketogenic-diet biology to this disorder
is not itself tested, hence INDIRECT.
quote_role: BACKGROUND
evidence:
- reference: PMID:32395403
reference_title: Ketogenic diet for treating alopecia in BCS1l-related mitochondrial disease (Bjornstad syndrome).
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
There was improved hair growth during MAD in this individual with BCS1l
related mitochondrial disease
explanation: >-
The primary observation, stated by the authors with the hedging their
single-patient design requires.
quote_role: PRIMARY_RESULT
directness: DIRECT
- reference: PMID:32395403
reference_title: Ketogenic diet for treating alopecia in BCS1l-related mitochondrial disease (Bjornstad syndrome).
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Figure 1F shows that the hair was lost again 6 months after cessation of
MAD.
explanation: >-
Withdrawal and relapse in the same patient is the strongest element of this
report, though it remains a single uncontrolled observation.
quote_role: PRIMARY_RESULT
directness: DIRECT
- reference: PMID:32395403
reference_title: Ketogenic diet for treating alopecia in BCS1l-related mitochondrial disease (Bjornstad syndrome).
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
A 3‐day dietary history indicated an adequate diet with no protein deficiency but aminoaciduria, as a
possible contributing cause for alopecia, was not confirmed or excluded.
explanation: >-
The report identifies a possible confounder of the hair response.
quote_role: PRIMARY_RESULT
notes: >-
This single observation does not establish a disease-modifying therapy or the safety and efficacy of a
ketogenic diet across patients. The family stopped because of carbohydrate cravings and lack of hearing
improvement.
- name: Genetic counseling
description: >-
For two confirmed heterozygous carrier parents, each pregnancy has a Mendelian 25% probability of a child
with the biallelic genotype. Counseling should use the familial variants and clinical spectrum, and explain
that outcomes cannot be predicted from one allele alone.
therapeutic_modality: BEHAVIORAL
treatment_term:
preferred_term: Genetic Counseling
term:
id: NCIT:C15240
label: Genetic Counseling
evidence:
- reference: PMID:17314340
reference_title: Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The Björnstad syndrome, an autosomal recessive disorder associated with
sensorineural hearing loss and pili torti, is caused by mutation of a
previously unidentified gene on chromosome 2q34-36.
explanation: >-
The recessive inheritance that determines the recurrence risk discussed in
counseling.
quote_role: BACKGROUND
directness: DIRECT
- name: Hearing aids and audiologic follow-up
description: >-
Hearing aids and ongoing audiologic assessment are used for the hearing phenotype. Benefit and need for
implantation depend on individual hearing severity and response.
therapeutic_modality: DEVICE
treatment_term:
preferred_term: hearing-aid rehabilitation
term:
id: NCIT:C15315
label: Rehabilitation
target_phenotypes:
- preferred_term: Sensorineural hearing impairment
term:
id: HP:0000407
label: Sensorineural hearing impairment
evidence:
- reference: url:https://cmb.ump.edu.vn/upload/userfiles/images/B%C3%80I%20B%C3%81O/2021_Alopecia%20and%20hearing%20loss%20in%20a%20boy.pdf
reference_title: https://cmb.ump.edu.vn/upload/userfiles/images/B%C3%80I%20B%C3%81O/2021_Alopecia%20and%20hearing%20loss%20in%20a%20boy.pdf
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
had begun wearing hearing aids at the age of 4 years.
explanation: >-
The case documents audiologic follow-up and hearing-aid use, without quantifying benefit.
quote_role: PRIMARY_RESULT
- name: Gentle hair care
description: >-
Avoiding excessive grooming, heat, chemical treatment and mechanical trauma can reduce damage to fragile
hair. This is general pili-torti care, not evidence that BCS1L function is restored.
therapeutic_modality: BEHAVIORAL
treatment_term:
preferred_term: gentle hair care and avoidance of shaft trauma
target_phenotypes:
- preferred_term: Brittle hair
term:
id: HP:0002299
label: Brittle hair
evidence:
- reference: PMID:34501349
reference_title: 'Pili Torti: A Feature of Numerous Congenital and Acquired Conditions.'
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: INDIRECT
snippet: >-
There is no specific treatment of pili torti. The avoidance of trauma to the hair is recommended.
explanation: >-
The review supports general supportive care for hair fragility.
quote_role: REVIEW_SYNTHESIS
discussions:
- discussion_id: bjornstad_tissue_restriction
kind: KNOWLEDGE_GAP
prompt: >-
Why do many BCS1L genotypes preferentially affect hearing and hair, while other genotypes cause broader
organ disease?
attaches_to:
- pathophysiology#Excess Reactive Oxygen Species Production
- pathophysiology#Cochlear Oxidative Injury
rationale: >-
Increased cellular ROS and a mitochondrial-content difference were observed in the original mutant comparison,
but neither establishes why particular tissues are affected. The reviewed sources do not provide allele-matched
cochlear and follicular measurements. Additional clinical manifestations can occur, so tissue restriction
is relative. Comparable oxidative burden can have different consequences because tissues differ in repair,
antioxidant capacity and energy demand.
proposed_experiments:
- experiment_id: bjornstad_allele_matched_tissue_ros
name: Allele-matched tissue comparison of oxidative burden
description: >-
Compare matched biallelic Bjornstad and severe BCS1L genotypes in isogenic human iPSC-derived inner-ear,
hair-follicle and hepatic models. Measure complex III assembly, respiration, ROS, cell survival and follicular
organization, and add genetic correction plus independently verified ROS-lowering interventions.
would_support:
- pathophysiology#Cochlear Oxidative Injury
supporting_outcome:
- Cochlear and follicular dysfunction tracks with oxidative injury and improves when ROS is normalized, with effects distinguished from restoration of respiration.
would_refute:
- pathophysiology#Cochlear Oxidative Injury
refuting_outcome:
- Cochlear and follicular injury persists despite sustained normalization of ROS with multiple validated interventions, while BCS1L correction rescues the phenotype; this would argue against ROS as the principal mediator.
evidence:
- reference: PMID:17314340
reference_title: Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome.
supports: SUPPORT
evidence_source: OTHER
directness: INDIRECT
snippet: >-
Mutations that cause the Björnstad syndrome illustrate the exquisite sensitivity of ear and hair tissues
to mitochondrial function, particularly to the production of reactive oxygen species.
explanation: >-
This is the authors' mechanistic interpretation of the clinical and biochemical findings, not a direct
tissue-specific oxidative-injury experiment.
quote_role: PRIMARY_RESULT
- discussion_id: bjornstad_no_faithful_model
kind: HUMAN_MODEL_MISMATCH
prompt: >-
Which experimental systems can reproduce the hair and hearing phenotype for clinically matched BCS1L genotypes?
attaches_to:
- pathophysiology#Complex III Assembly Defect
rationale: >-
The reviewed patient-cell, yeast, HeLa and purified-protein systems resolve assembly or substrate interactions
but do not reproduce a cochlea and hair follicle together. Severe BCS1L animal models cannot automatically
validate a predominantly hair-and-hearing mechanism. A disease-matched tissue model remains a gap in this
evidence set; this is not an exhaustive claim that no relevant model exists.
evidence:
- reference: PMID:40660675
reference_title: "BCS1L-Associated Disease: 5'-UTR Variant Shifts the Phenotype Towards Axonal Neuropathy."
supports: SUPPORT
evidence_source: IN_VITRO
directness: DIRECT
snippet: >-
Co‐immunoprecipitation assays showed that p.L280F exhibited markedly reduced interaction with UQCRFS1,
similar to the severe GRACILE‐associated S78G variant, whereas p.R183H retained partial binding (Figure
3G).
explanation: >-
The HeLa-cell assay includes a Bjornstad-associated comparator, p.Arg183His. It measures protein association,
not ATPase turnover or translocation rate.
quote_role: PRIMARY_RESULT
- reference: PMID:38821922
reference_title: Conformations of Bcs1L undergoing ATP hydrolysis suggest a concerted translocation mechanism for folded iron-sulfur protein substrate.
supports: SUPPORT
evidence_source: IN_VITRO
directness: INDIRECT
snippet: >-
Our results show that Bcs1L transitions directly between the ATP and ADP conformations, with no indication
of the existence of additional intermediate forms, supporting a concerted mechanism.
explanation: >-
Purified wild-type mouse Bcs1L with a bovine Rieske extrinsic-domain substrate informs normal transport
architecture. It does not establish the molecular defect of a human Bjornstad allele.
quote_role: PRIMARY_RESULT
- discussion_id: bjornstad_variant_mechanisms
kind: KNOWLEDGE_GAP
prompt: Which biochemical steps distinguish individual Bjornstad genotypes from other BCS1L presentations?
attaches_to:
- pathophysiology#BCS1L Rieske Protein Insertion Failure
rationale: >-
The 2007 residue-interface versus ATP-site classification was a homology-based explanation of the alleles
studied then. New wild-type structural work and residual Rieske binding by p.Arg183His refine the model
but do not prove normal ATP turnover for every Bjornstad variant. Reported compound genotypes can pair
alleles associated with different clinical spectra, including a missense/nonsense combination. Assays of
the complete genotype and multiple steps in transport are needed.
evidence:
- reference: PMID:17314340
reference_title: Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome.
supports: SUPPORT
evidence_source: COMPUTATIONAL
directness: DIRECT
snippet: >-
Patients with the Björnstad syndrome have mutations that alter residues involved in protein-protein interactions,
whereas mutations in patients with complex III deficiency alter ATP-binding residues, as deduced from
the crystal structure of a related AAA-family ATPase.
explanation: >-
The residue-role assignments are computational deductions for the original mutant set, not a universal
clinical classification.
quote_role: PRIMARY_RESULT
- reference: PMID:40660675
reference_title: "BCS1L-Associated Disease: 5'-UTR Variant Shifts the Phenotype Towards Axonal Neuropathy."
supports: SUPPORT
evidence_source: IN_VITRO
directness: DIRECT
snippet: >-
Co‐immunoprecipitation assays showed that p.L280F exhibited markedly reduced interaction with UQCRFS1,
similar to the severe GRACILE‐associated S78G variant, whereas p.R183H retained partial binding (Figure
3G).
explanation: >-
The HeLa-cell assay includes a Bjornstad-associated comparator, p.Arg183His. It measures protein association,
not ATPase turnover or translocation rate.
quote_role: PRIMARY_RESULT
- reference: PMID:39053894
reference_title: 'Pathological variants in nuclear genes causing mitochondrial complex III deficiency: An update.'
supports: SUPPORT
evidence_source: OTHER
directness: INDIRECT
snippet: >-
However, despite these developments, the molecular pathological mechanisms underlying the clinical heterogeneity
in different cases of mitochondrial cIII deficiency are still not fully comprehended.
explanation: >-
The review describes unresolved clinical heterogeneity across complex III disorders, providing broader
context rather than allele-specific experimental proof.
quote_role: REVIEW_SYNTHESIS
mechanistic_hypotheses:
- hypothesis_group_id: ROS_TISSUE_VULNERABILITY
hypothesis_label: Preferential oxidative injury in cochlear and follicular tissues
status: EMERGING
description: >-
Cellular ROS abnormalities and the predominantly hair-and-hearing phenotype support a proposed oxidative-vulnerability
model. Direct measurement and rescue in the affected tissues are needed to establish these causal links;
occasional additional clinical findings and cochlear malformations are not explained by the model.
evidence:
- reference: PMID:17314340
reference_title: Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome.
supports: SUPPORT
evidence_source: OTHER
directness: INDIRECT
snippet: >-
Mutations that cause the Björnstad syndrome illustrate the exquisite sensitivity of ear and hair tissues
to mitochondrial function, particularly to the production of reactive oxygen species.
explanation: >-
This is the authors' mechanistic interpretation of the clinical and biochemical findings, not a direct
tissue-specific oxidative-injury experiment.
quote_role: PRIMARY_RESULT
references:
- reference: PMID:11807445
title: 'Three members of a family with pili torti and sensorineural hearing loss: the Bjornstad syndrome.'
- reference: PMID:17314340
title: Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome.
- reference: PMID:22991165
title: Clinical and biochemical features associated with BCS1L mutation.
- reference: PMID:24172246
title: Novel mutation in AAA domain of BCS1L causing Bjornstad syndrome.
- reference: PMID:25895478
title: Exome sequencing reveals novel BCS1L mutations in siblings with hearing loss and hypotrichosis.
- reference: PMID:27882597
title: Morphological analyses in fragility of pili torti with Björnstad syndrome.
- reference: PMID:28322498
title: Novel compound heterozygous mutations in BCS1L gene causing Bjornstad syndrome in two siblings.
- reference: PMID:30582773
title: Clinical spectrum of BCS1L Mitopathies and their underlying structural relationships.
- reference: PMID:31435670
title: Molecular genetic investigations identify new clinical phenotypes associated with BCS1L-related mitochondrial disease.
- reference: PMID:32395403
title: Ketogenic diet for treating alopecia in BCS1l-related mitochondrial disease (Bjornstad syndrome).
- reference: PMID:34501349
title: 'Pili Torti: A Feature of Numerous Congenital and Acquired Conditions.'
- reference: PMID:37816838
title: 'Cochlear implantation in Bjornstad syndrome: a case series with literature review.'
- reference: PMID:38821922
title: Conformations of Bcs1L undergoing ATP hydrolysis suggest a concerted translocation mechanism for folded iron-sulfur protein substrate.
- reference: PMID:39053894
title: 'Pathological variants in nuclear genes causing mitochondrial complex III deficiency: An update.'
- reference: PMID:40660675
title: "BCS1L-Associated Disease: 5'-UTR Variant Shifts the Phenotype Towards Axonal Neuropathy."
- reference: PMID:41466500
title: 'Björnstad Syndrome With Late-Onset Alopecia Mimicking Androgenetic Alopecia: Histopathological and Genetic Findings.'
- reference: PMID:41814923
title: Combination therapy with tofacitinib and minoxidil for Bjornstad syndrome caused by novel BCS1L gene variants.
- reference: url:https://cmb.ump.edu.vn/upload/userfiles/images/B%C3%80I%20B%C3%81O/2021_Alopecia%20and%20hearing%20loss%20in%20a%20boy.pdf
title: https://cmb.ump.edu.vn/upload/userfiles/images/B%C3%80I%20B%C3%81O/2021_Alopecia%20and%20hearing%20loss%20in%20a%20boy.pdf
Deep research results are used as seeds for research; they do not undergo the same validation as the main records and may contain errors. How we use deep research.
Review round 1: term, evidence-grading and literature-sweep fixes · 2026-09-04T06:01:31Z · View source
Addresses the CHANGES_REQUESTED review on PR #10895. (1) Replaced GO:0016887 ATP hydrolysis activity / DECREASED on BCS1L Rieske Protein Insertion Failure with GO:0140662 ATP-dependent protein folding chaperone and no modifier: the cited paper says Bjornstad alleles alter protein-protein interaction residues and that only complex III deficiency alleles disrupt ATP-dependent assembly, so a decreased ATPase rate was the opposite of the evidence. (2) Replaced GO:0016226 iron-sulfur cluster assembly with GO:0045039 protein insertion into mitochondrial inner membrane / DECREASED; GO:0016226 is de novo Fe-S cluster biosynthesis, which BCS1L does not do. (3) Re-graded three PMID:17314340 evidence items away from HUMAN_CLINICAL: two functional-analysis results to IN_VITRO and the homology-model residue assignment to COMPUTATIONAL. (4) Manual PubMed sweep in place of a deep-research artifact (33 hits for Bjornstad syndrome, 106 for BCS1L, all screened by title). It found PMID:37816838, a 2024 cochlear implantation case series that the entry did not cite and whose existence contradicted a notes claim that no Bjornstad-specific implantation series had been published; added two evidence items to the implantation treatment, corrected the notes, and added a new phenotype Incomplete partition of the cochlea type I (HP:0011374) reported bilaterally in both siblings. Confirmed no GeneReviews chapter exists for Bjornstad syndrome; the single BCS1L GeneReviews hit (PMID:26425749) is the nuclear-gene Leigh syndrome spectrum overview. (5) Review suggestions taken: HP:0000750 bound to Speech and language delay; GO:0006979 response to oxidative stress added to the conforming cochlear node so the module conformance is checkable, with the omitted potassium branch and the skipped hair-cell-death node explained in the node description; Brittle hair given notes explaining why no frequency band is assigned. Kept PMID:27882597 graded IN_VITRO: transmission electron microscopy and tensile testing of plucked hair is an ex vivo specimen assay, which CLAUDE.md classifies as IN_VITRO. Validated with just validate, validate-terms, count-verified-snippets (34/34), check-entity-refs, check-duplicate-keys, check-causal-targets, check-enum-values, check-qualifier-terms.
Scope and evidence date. This report distinguishes classic Björnstad syndrome—pili torti with sensorineural hearing loss—from severe multisystem BCS1L-related complex III disease. Evidence for the classic syndrome remains limited to small pedigrees and case reports; consequently, percentages, penetrance estimates, survival curves, and treatment-response rates generally cannot be calculated reliably.
Björnstad syndrome is an extremely rare, autosomal-recessive mitochondrial disorder caused by biallelic germline variants in BCS1L. Its defining manifestations are congenital or early-childhood bilateral sensorineural hearing loss and pili torti, a hair-shaft defect in which flattened shafts twist approximately 180° at irregular intervals. Open Targets identifies BCS1L as the only associated target for Björnstad syndrome, MONDO:0009872. Classic disease is usually limited to hair and hearing and is considered the mild end of the BCS1L phenotypic spectrum; renal, hepatic, neurologic, cardiac, or severe metabolic involvement should prompt classification as broader BCS1L-related mitochondrial disease rather than uncomplicated Björnstad syndrome. (OpenTargets Search: Bjornstad syndrome-BCS1L, hinson2007missensemutationsin pages 1-2, tegelberg2017respiratorychaincomplex pages 1-2)
The major recent advance is mechanistic rather than therapeutic. A May 2024 cryo-EM study showed that the BCS1L heptamer uses a concerted ATPase cycle to translocate folded Rieske iron–sulfur protein during late respiratory-complex-III assembly. A July 2024 review confirms that BCS1L variants are the most frequent nuclear genetic cause of complex III deficiency. No approved disease-modifying therapy or Björnstad-specific interventional trial was identified. (zhan2024conformationsofbcs1l pages 1-2, cunatova2024pathologicalvariantsin pages 1-4, cunatova2024pathologicalvariantsin pages 5-7)
The following table provides a compact knowledge-base mapping; the narrative afterward expands the principal fields.
| Knowledge-base field | Classic Björnstad syndrome | Broader BCS1L-related disease / ontology annotation | Evidence |
|---|---|---|---|
| Disease identity and identifiers | Rare Mendelian mitochondrial disorder defined by pili torti plus bilateral sensorineural hearing loss. Synonyms: Björnstad syndrome, Bjornstad syndrome, pili torti–sensorineural hearing loss syndrome. MONDO:0009872; OMIM phenotype: 262000. | Do not equate classic Björnstad syndrome with GRACILE syndrome or all BCS1L-related complex III deficiencies. OMIM 603647 refers to BCS1L, not the classic phenotype. A dedicated ICD-10/ICD-11 or MeSH disease code was not established in the reviewed evidence. | (OpenTargets Search: Bjornstad syndrome-BCS1L, hinson2007missensemutationsin pages 1-2, blazquez2013mitochondrialcomplexiii pages 7-10) |
| Inheritance | Autosomal recessive; affected individuals generally have biallelic germline BCS1L variants. For two carrier parents, expected Mendelian risks per pregnancy are 25% affected, 50% carrier and 25% unaffected/non-carrier. | Variable expressivity occurs across BCS1L genotypes. Anticipation, protective alleles and established germline-mosaicism effects have not been demonstrated. Consanguinity increases the probability of homozygous disease alleles but is not required. | (hinson2007missensemutationsin pages 1-2, siddiqi2013novelmutationin pages 1-2, trinh2021alopeciaandhearing pages 1-2) |
| Causal gene and protein | BCS1L is the sole established causal gene; it encodes a 419-aa, inner-mitochondrial-membrane AAA-family ATPase/chaperone. Open Targets identifies BCS1L as the only associated target for MONDO:0009872. | Protein architecture includes an N-terminal mitochondrial targeting/transmembrane region, a Bcs1-specific middle domain and a C-terminal AAA ATPase domain. BCS1L acts during late complex III maturation. | (OpenTargets Search: Bjornstad syndrome-BCS1L, hinson2007missensemutationsin pages 1-2, zhan2024conformationsofbcs1l pages 2-3, blazquez2013mitochondrialcomplexiii pages 7-10) |
| Core phenotype: hearing | Congenital or first-year-onset, bilateral sensorineural/cochlear hearing impairment; severity ranges from moderate to profound and may progress. One five-patient pedigree had thresholds of 70–110 dB, with moderate-to-severe childhood and severe-to-profound adult loss. Suggested HPO: Sensorineural hearing impairment (HP:0000407), bilateral hearing impairment, congenital hearing impairment, progressive hearing impairment. | Conductive loss, absent auditory canals, encephalopathy or seizures suggest a broader phenotype or another diagnosis rather than uncomplicated classic Björnstad syndrome. | (siddiqi2013novelmutationin pages 1-2, trinh2021alopeciaandhearing pages 1-2, qurashi2022clinicalanddiagnostic pages 1-2) |
| Core phenotype: hair | Pili torti consists of flattened hair shafts twisted approximately 180° at irregular intervals, producing coarse, lusterless, brittle scalp hair, hypotrichosis or nonscarring alopecia. Hair loss may begin at 2–3 months. Suggested HPO: Pili torti, brittle hair, sparse scalp hair/hypotrichosis, nonscarring alopecia. | Eyebrow, eyelash or body-hair involvement is variable; one pedigree had eyelash loss, whereas another case had normal eyebrows and eyelashes. Pili torti is not specific and also occurs in Menkes disease and other inherited or acquired disorders. | (siddiqi2013novelmutationin pages 1-2, trinh2021alopeciaandhearing pages 1-2) |
| Other reported phenotypes | Occasional short stature, anhidrosis, light-colored eyes or intellectual disability have been reported, but frequencies and causal specificity are uncertain. Teeth, nails, palms and soles may be normal. | Renal Fanconi/tubular disease, lactic acidosis, liver failure, growth restriction, microcephaly, cardiomyopathy, encephalopathy and early death belong mainly to the broader BCS1L complex III-deficiency spectrum, not the defining classic phenotype. Suggested HPO terms should be attached only when observed in the individual. | (siddiqi2013novelmutationin pages 1-2, qurashi2022clinicalanddiagnostic pages 1-2, jackson2016anovelmutation pages 1-2, cunatova2024pathologicalvariantsin pages 5-7) |
| Example classic-associated variants | Reported biallelic variants include homozygous c.901T>A (p.Tyr301Asn) and compound-heterozygous c.649G>C (p.Asp217His) plus c.671G>A (p.Arg224His). The p.Tyr301Asn allele segregated in five affected relatives and was absent from 137 Pakistani controls and 1000 Genomes. | Variant classification must use current ClinVar/ACMG evidence, segregation, population frequency and functional data; a published “novel” or predicted-damaging result alone is not equivalent to a current pathogenic classification. | (siddiqi2013novelmutationin pages 1-2, trinh2021alopeciaandhearing pages 1-2) |
| Broader-spectrum variant examples | Not defining examples of uncomplicated Björnstad syndrome. | c.142A>G (p.Met48Val) was associated with deafness, tubulopathy, growth retardation and microcephaly; c.712A>G (p.Ser328Gly) with severe multisystem neonatal disease; and c.548G>A (p.Arg183His) plus c.1061_1062insCTA (p.Gly354delinsGlyTyr) with complex III deficiency and multisystem manifestations. | (qurashi2022clinicalanddiagnostic pages 1-2, jackson2016anovelmutation pages 1-2) |
| Ordered molecular mechanism | Biallelic BCS1L dysfunction leads to defective late-stage complex III assembly; this results in reduced respiratory-chain function and altered redox handling; tissue-selective energetic/oxidative injury is inferred to cause dysfunction of cochlear sensory cells and hair follicles; this leads to hearing loss and pili torti. | BCS1L normally translocates folded, Fe–S-cluster-containing UQCRFS1/Rieske ISP from the matrix side across the inner membrane and inserts it into nascent complex III. Failed insertion causes Rieske-deficient precomplex accumulation, impaired complex III/respirasome assembly and altered ROS. Suggested GO: mitochondrial respiratory-chain complex III assembly; protein translocation across mitochondrial inner membrane; ubiquinol-to-cytochrome-c electron transport; oxidative phosphorylation; response to oxidative stress. | (hinson2007missensemutationsin pages 1-2, tegelberg2017respiratorychaincomplex pages 1-2, hinson2007missensemutationsin pages 9-10, cunatova2024pathologicalvariantsin pages 1-4, cunatova2024pathologicalvariantsin pages 5-7) |
| Key 2024 mechanistic development | The structural work explains the normal machine affected by Björnstad variants but does not itself establish variant-specific clinical effects. | Cryo-EM showed heptameric BCS1L subunits switching concertedly between uniform ATP- and ADP-bound conformations rather than using a sequential threading staircase. Folded ISP can be trapped in the all-ADP state and is proposed to be released in the apo state; ISP stimulated ATPase activity by about 50%. A 2024 review identifies BCS1L variants as the most frequent nuclear cause of complex III deficiency. | (zhan2024conformationsofbcs1l pages 1-2, zhan2024conformationsofbcs1l pages 2-3, cunatova2024pathologicalvariantsin pages 1-4, cunatova2024pathologicalvariantsin pages 5-7) |
| Anatomy, cells and compartments | Primary sites: cochlea/inner ear and scalp hair follicle/hair shaft. Suggested UBERON: cochlea, organ of Corti, inner ear, skin of scalp, hair follicle. Suggested CL: auditory hair cell, inner hair cell, outer hair cell, hair-follicle keratinocyte. | Subcellular sites: mitochondrial inner membrane (GO:0005743), mitochondrial matrix, respiratory-chain complex III (GO:0005750) and respirasome (GO:0070469). Exact vulnerable cell population in human Björnstad syndrome remains incompletely demonstrated; localization to cochlear and follicular cells is partly inferential. | (hinson2007missensemutationsin pages 1-2, trinh2021alopeciaandhearing pages 1-2, zhan2024conformationsofbcs1l pages 1-2, cunatova2024pathologicalvariantsin pages 1-4) |
| Diagnosis | Suspect from the combination of early bilateral sensorineural hearing loss and brittle/sparse hair. Confirm pili torti by trichoscopy or light/electron microscopy and characterize hearing with age-appropriate audiometry, otoacoustic emissions and auditory brainstem testing. Confirm with two clinically significant BCS1L variants in trans and parental segregation where possible. | A hearing-loss/mitochondrial gene panel, WES or WGS is appropriate when single-gene testing is negative or the phenotype is broad. Respiratory-chain enzyme assays, blue-native PAGE and muscle/fibroblast studies can support pathogenicity, but complex III deficiency may be tissue-dependent or missed by routine assays. CMA, karyotype, FISH, mtDNA and repeat-expansion tests are not first-line for the classic phenotype unless other findings indicate them. | (trinh2021alopeciaandhearing pages 1-2, tegelberg2017respiratorychaincomplex pages 1-2, jackson2016anovelmutation pages 1-2) |
| Differential diagnosis | Crandall syndrome may combine pili torti and hearing loss but includes hypogonadism. Other considerations include Menkes disease, isolated pili torti, ectodermal dysplasias, Netherton syndrome and acquired pili torti. | Multisystem metabolic disease requires evaluation for GRACILE syndrome, broader BCS1L mitopathy and other nuclear complex III disorders. Genetic testing is important because pili torti is a nonspecific hair-shaft marker. | (trinh2021alopeciaandhearing pages 1-2) |
| Treatment and implementation | No curative or approved genotype-specific therapy. Early audiology, hearing aids, speech/language support and educational accommodations are standard; cochlear implantation may be considered for severe/profound loss under usual audiological criteria. Gentle hair care and cosmetic support address fragility. Suggested NCIT concepts: Hearing Aid Device, Cochlear Implantation, Speech Therapy, Genetic Counseling. | Broader disease warrants mitochondrial-specialist surveillance and organ-directed care. Vitamin/CoQ10 “cocktails” have only anecdotal evidence and cannot be considered proven Björnstad therapy. No Björnstad-specific interventional trial was identified. | (trinh2021alopeciaandhearing pages 1-2) |
| Prognosis and quality of life | Classic disease is chronic and lifelong; hearing impairment can substantially affect communication, language, education and employment, while hair abnormalities mainly affect appearance and psychosocial well-being. Classic Björnstad syndrome is generally described as compatible with normal lifespan. | Prognosis cannot be extrapolated from classic disease to severe BCS1L mitopathy, in which hepatic, renal, neurologic or cardiac involvement may cause early mortality. No syndrome-specific survival curves, validated quality-of-life scores or prognostic biomarkers were found. | (siddiqi2013novelmutationin pages 1-2, blazquez2013mitochondrialcomplexiii pages 7-10, cunatova2024pathologicalvariantsin pages 5-7) |
| Epidemiology and population | Described as extremely rare; no reliable population prevalence, incidence, carrier frequency or sex ratio was found. Both sexes are affected. Reports span multiple geographic ancestries and are dominated by individual cases and small pedigrees. | Consanguineous families have enabled discovery of homozygous alleles, but no classic Björnstad founder effect is established in the reviewed evidence. Do not calculate prevalence from published case counts because ascertainment and publication bias are substantial. | (hinson2007missensemutationsin pages 1-2, siddiqi2013novelmutationin pages 1-2, trinh2021alopeciaandhearing pages 1-2) |
| Prevention and screening | The genotype cannot be prevented by lifestyle or vaccination. Cascade testing, carrier testing of adult relatives, genetic counseling, prenatal diagnosis and PGT-M are possible after familial variants are established. Population newborn screening is not available; early hearing screening can reduce developmental consequences. | No environmental protective factor, gene–environment interaction or prophylactic medication has been established. Avoiding excessive mechanical/chemical hair trauma may reduce breakage but does not alter mitochondrial disease. | (hinson2007missensemutationsin pages 1-2, trinh2021alopeciaandhearing pages 1-2) |
| Models and comparative biology | No validated animal model was found that specifically reproduces the classic hair-plus-hearing Björnstad phenotype. No naturally occurring veterinary counterpart or zoonotic/transmission relevance was identified. | Yeast Saccharomyces cerevisiae Bcs1 models support variant validation and compound screening. Bcs1l mutant/knock-in mice reproduce aspects of broader complex III deficiency, hepatopathy and macrophage abnormalities, but only partially phenocopy human multisystem disease and should not be treated as classic Björnstad models. | (tegelberg2017respiratorychaincomplex pages 1-2, zhan2024conformationsofbcs1l pages 1-2, blazquez2013mitochondrialcomplexiii pages 7-10) |
| Key evidence gaps | Phenotype frequencies, penetrance, natural-history trajectories, hearing progression rates, quality of life and long-term intervention outcomes remain undefined because evidence consists mainly of case reports and small families. | No validated modifier genes, protective variants, epigenetic signature, disease-specific transcriptomic/proteomic/metabolomic profile, single-cell or spatial atlas, prognostic biomarker, classic-syndrome animal model, disease-modifying therapy or dedicated clinical trial was identified. The mechanism of selective cochlear and follicular vulnerability remains partly inferred. | (hinson2007missensemutationsin pages 9-10, trinh2021alopeciaandhearing pages 2-2, zhan2024conformationsofbcs1l pages 1-2, cunatova2024pathologicalvariantsin pages 5-7) |
Table: Concise knowledge-base mapping of classic Björnstad syndrome, with explicit separation from severe BCS1L-related complex III disease. It integrates clinical, genetic, mechanistic, ontology, diagnostic and management fields while highlighting 2024 structural advances and evidence gaps.
The evidence summarized here is aggregated disease-level literature and database evidence, not individual EHR data. Patient-level observations come from published pedigrees and case reports.
Hinson et al., New England Journal of Medicine, published 22 February 2007, established recessive BCS1L variants as causal and performed human cellular functional studies (PMID 17314340; DOI/URL: https://doi.org/10.1056/NEJMoa055262). The study describes congenital, variably severe sensorineural hearing loss and childhood-recognized pili torti. (OpenTargets Search: Bjornstad syndrome-BCS1L, hinson2007missensemutationsin pages 1-2)
The primary cause is genetic: two clinically significant germline BCS1L alleles in trans. BCS1L is nuclear encoded; Björnstad syndrome is not caused by an mtDNA variant. In consanguineous families, homozygous alleles are more likely, but consanguinity is not required. Examples include a homozygous p.Tyr301Asn pedigree and compound-heterozygous p.Asp217His/p.Arg224His disease. (siddiqi2013novelmutationin pages 1-2, trinh2021alopeciaandhearing pages 1-2)
For two heterozygous carrier parents, the expected risk per pregnancy is 25% affected, 50% carrier, and 25% unaffected/non-carrier. Published observations support variable expressivity, especially in hearing severity, but robust penetrance estimates are unavailable. No validated susceptibility loci, modifier genes, protective alleles, anticipation, or disease-relevant epigenetic mechanism were identified.
No environmental toxin, lifestyle exposure, infectious agent, or gene–environment interaction is established as a cause. Avoiding traction, heat, bleaching, and harsh chemical treatment may reduce breakage of already fragile hair, but it does not modify the mitochondrial lesion. Diet, smoking, alcohol, exercise, vaccination, and occupational exposure have no demonstrated effect on occurrence of the Mendelian disorder.
Published cases demonstrate variability. A six-year-old had hair shedding and hearing loss by age one, profound cochlear loss, intellectual disability, and normal eyebrows, eyelashes, skin, nails, and testes. By contrast, the five-person pedigree included eyelash loss, anhidrosis, light eyes, short stature, and lean habitus in affected males, with normal teeth, nails, palms, and soles. These secondary features should be coded as case-level observations, not mandatory syndrome criteria. (siddiqi2013novelmutationin pages 1-2, trinh2021alopeciaandhearing pages 1-2)
The disorder is chronic and lifelong. Hearing impairment can substantially affect speech and language acquisition, education, social participation, and employment, particularly when intervention is delayed. Hair fragility is not generally medically dangerous but may produce cosmetic and psychosocial burden. No Björnstad-specific EQ-5D, SF-36, PROMIS, or longitudinal natural-history dataset was found.
There are no validated clinical stages or remission pattern. Hair density and hearing severity may vary, but spontaneous molecular remission is not expected. Infancy and early childhood constitute the critical intervention window for hearing habilitation and language development.
BCS1L encodes a 419-amino-acid, inner-mitochondrial-membrane AAA-family ATPase/chaperone. Its architecture comprises an N-terminal mitochondrial targeting/transmembrane region, a Bcs1-specific middle domain, and a C-terminal AAA ATPase domain. (hinson2007missensemutationsin pages 1-2, zhan2024conformationsofbcs1l pages 2-3, blazquez2013mitochondrialcomplexiii pages 7-10)
Representative classic-associated variants include:
Broader-spectrum examples must not automatically be annotated as classic Björnstad alleles: homozygous c.142A>G, p.Met48Val caused deafness with Fanconi-type tubulopathy, growth retardation, microcephaly, and liver dysfunction; homozygous c.712A>G, p.Ser328Gly was associated with severe neonatal multisystem disease; and c.548G>A, p.Arg183His plus c.1061_1062insCTA, p.Gly354delinsGlyTyr occurred with complex III deficiency and neurologic, renal, hepatic, and metabolic manifestations. (qurashi2022clinicalanddiagnostic pages 1-2, jackson2016anovelmutation pages 1-2)
Published labels such as “novel,” “predicted pathogenic,” or “disease-associated” should not substitute for current ACMG/AMP assessment. A production database should retrieve current ClinVar assertions, gnomAD allele counts, transcript version, segregation, and functional evidence for each exact allele. The retrieved literature did not provide reliable current frequencies for every variant. No recurrent chromosomal abnormality, pathogenic aneuploidy, somatic origin, methylation signature, or repeat expansion is implicated.
Hinson et al. found disrupted complex III/respirasome assembly, reduced electron-transport activity, and increased ROS in variant-bearing cells. Björnstad-associated substitutions tended to map to externally exposed residues implicated in protein interactions, whereas severe alleles more directly affected ATP binding/hydrolysis. Complex I-derived superoxide was higher in severe complex-III mutations than in Björnstad mutations (P=0.04), supporting—but not proving—the proposed severity gradient. (hinson2007missensemutationsin pages 1-2, hinson2007missensemutationsin pages 9-10)
Zhan et al., Nature Communications, accepted 20 May 2024, used cryo-EM during active ATP hydrolysis. Their abstract states: “The human AAA-ATPase Bcs1L translocates the fully assembled Rieske iron-sulfur protein (ISP) precursor across the mitochondrial inner membrane, enabling respiratory Complex III assembly.” The subunits moved directly and uniformly between ATP- and ADP-associated conformations without detectable mixed nucleotide intermediates, favoring a concerted, rather than sequential staircase/threading, mechanism. Folded ISP could be trapped in the all-ADP state and was proposed to be released in the apo state; purified ISP stimulated ATPase activity by approximately 50%. DOI/URL: https://doi.org/10.1038/s41467-024-49029-y. (zhan2024conformationsofbcs1l pages 1-2, zhan2024conformationsofbcs1l pages 2-3)
The 2024 complex III review states: “Mitochondrial disorders are a group of clinically and biochemically heterogeneous genetic diseases within the group of inborn errors of metabolism.” It places BCS1L at the final UQCRFS1 insertion/activation step and identifies BCS1L variants as the most frequent among nuclear causes of complex III deficiency. Čunátová and Fernández-Vizarra, accepted 2 May 2024, published July 2024; DOI/URL: https://doi.org/10.1002/jimd.12751. (cunatova2024pathologicalvariantsin pages 1-4, cunatova2024pathologicalvariantsin pages 5-7)
The principal organs/tissues are the inner ear/cochlea, especially the auditory sensory apparatus, and scalp hair follicles/hair shafts. Suggested UBERON concepts are cochlea, organ of Corti, inner ear, skin of scalp, and hair follicle. Hearing loss is generally bilateral. Hair involvement is principally scalp hair; eyebrow, eyelash, and other body-hair involvement is variable. (siddiqi2013novelmutationin pages 1-2, trinh2021alopeciaandhearing pages 1-2)
Renal tubules, liver, brain, skeletal muscle, and heart are secondary sites in broader BCS1L mitopathy, not required anatomical targets in classic Björnstad syndrome. A patient with p.Met48Val showed muscle-specific complex III deficiency absent in fibroblasts, illustrating tissue dependence of biochemical testing. (jackson2016anovelmutation pages 1-2)
Onset is congenital to early pediatric and generally insidious rather than acute. Hearing impairment may progress; pili torti and hair fragility are usually apparent in infancy or childhood. Classic disease is lifelong and generally considered compatible with normal lifespan, whereas severe BCS1L-related disease can cause early death. (siddiqi2013novelmutationin pages 1-2, blazquez2013mitochondrialcomplexiii pages 7-10, cunatova2024pathologicalvariantsin pages 5-7)
No credible prevalence per 100,000, incidence, carrier frequency, or sex ratio was identified. Both males and females are affected, as expected for autosomal-recessive inheritance. Reports include families from multiple geographic ancestries. Consanguinity has facilitated discovery of homozygous alleles, but no classic Björnstad founder effect was established. There is no evidence of genetic anticipation. Published case counts should not be converted into prevalence because ascertainment and publication bias are severe.
CMA, karyotyping, FISH, mitochondrial-genome sequencing, and repeat-expansion testing are not first-line tests for a classic phenotype unless independent features indicate them. No circulating biomarker, metabolite, pathology criterion, or imaging finding is diagnostic.
Important alternatives include Crandall syndrome—pili torti and hearing loss with hypogonadism—Menkes disease, isolated pili torti, Netherton syndrome, ectodermal dysplasias, and acquired pili torti associated with inflammatory alopecias, malnutrition, systemic disease, or medications. Broader metabolic findings require consideration of GRACILE syndrome, other BCS1L mitopathies, and defects of other complex III assembly genes. (trinh2021alopeciaandhearing pages 1-2)
No 5- or 10-year survival statistics, disease-specific mortality rates, or validated prognostic biomarkers exist for classic Björnstad syndrome. Available literature describes it as the mildest BCS1L phenotype and generally compatible with normal lifespan. Principal morbidity is permanent hearing disability and its developmental consequences; hair fragility is lifelong but not ordinarily life-threatening. (blazquez2013mitochondrialcomplexiii pages 7-10)
Prognosis changes materially when lactic acidosis, failure to thrive, tubulopathy, hepatic dysfunction, encephalopathy, seizures, cardiomyopathy, or profound developmental abnormalities are present. Such patients occupy the broader BCS1L disease spectrum, where early mortality can occur, and should not be counseled using classic Björnstad expectations. (qurashi2022clinicalanddiagnostic pages 1-2, jackson2016anovelmutation pages 1-2, cunatova2024pathologicalvariantsin pages 5-7)
There is no curative or approved BCS1L-directed pharmacotherapy, gene therapy, RNA therapy, cell therapy, or precision small-molecule treatment.
A 2020 multisystem case used CoQ10, carnitine, and vitamins alongside seizure therapy and reported short-term clinical improvement, but this is uncontrolled anecdotal evidence from complex III deficiency—not proof of efficacy in classic Björnstad syndrome. Vitamin or “mitochondrial cocktail” therapy should therefore not be represented as established treatment. (qurashi2022clinicalanddiagnostic pages 1-2)
No Björnstad-specific ClinicalTrials.gov interventional study was identified. Pharmacogenomic recommendations, treatment-response rates, and syndrome-specific adverse-event statistics are unavailable.
Primary prevention by lifestyle, vaccination, or environmental modification is not applicable to a recessive germline disorder. Clinically meaningful prevention focuses on recurrence and complications:
Population newborn molecular screening is not established. Vaccination, antimicrobial prophylaxis, and public-health environmental controls are not disease-specific interventions.
No naturally occurring veterinary equivalent, breed association, zoonotic potential, or cross-species transmission is known. BCS1L orthologues are evolutionarily conserved, but Björnstad syndrome is not infectious.
Saccharomyces cerevisiae Bcs1 has been central to defining ATP-dependent insertion/translocation of folded Rieske protein and can be used for variant validation and phenotype-based drug screening. Mammalian Bcs1l knock-in/mutant mice reproduce aspects of broader complex III deficiency, hepatopathy, and tissue macrophage abnormalities. A 2017 mouse model partially phenocopied encephalomyopathic BCS1L disease, including abnormalities of microglia and Kupffer cells; it was not a validated model of the classic hair-plus-hearing syndrome. (tegelberg2017respiratorychaincomplex pages 1-2, blazquez2013mitochondrialcomplexiii pages 7-10)
No model was identified that robustly reproduces both human pili torti and progressive sensorineural hearing loss from a classic Björnstad allele. This limits preclinical evaluation of tissue-selective therapies.
The strongest causal evidence combines recessive segregation, absence/rarity in controls, human cell functional assays, and conserved structural biology. However, the clinical evidence base remains dominated by individual cases and small consanguineous pedigrees. Frequencies of secondary phenotypes, penetrance, progression rates, quality-of-life scores, carrier frequencies, and intervention outcomes are therefore unknown rather than zero.
The central unresolved question is why partial disruption of a ubiquitous respiratory-chain assembly factor preferentially injures cochlear and hair-follicle tissues in classic disease. No validated modifier gene, protective variant, environmental interaction, epigenetic signature, omics biomarker, prognostic model, classic animal model, or disease-modifying trial was found. The 2024 structural studies clarify the normal ATP-driven machine and create a framework for interpreting variants, but they do not yet supply a therapy. (hinson2007missensemutationsin pages 9-10, trinh2021alopeciaandhearing pages 2-2, zhan2024conformationsofbcs1l pages 1-2, cunatova2024pathologicalvariantsin pages 5-7)
References
(OpenTargets Search: Bjornstad syndrome-BCS1L): Open Targets Query (Bjornstad syndrome-BCS1L, 10 results). Buniello, A. et al. (2025). Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Research.
(hinson2007missensemutationsin pages 1-2): J. Travis Hinson, Valeria R. Fantin, Jost Schönberger, Noralv Breivik, Geir Siem, Barbara McDonough, Pankaj Sharma, Ivan Keogh, Ricardo Godinho, Felipe Santos, Alfonso Esparza, Yamileth Nicolau, Edgar Selvaag, Bruce H. Cohen, Charles L. Hoppel, Lisbeth Tranebjærg, Roland D. Eavey, J.G. Seidman, and Christine E. Seidman. Missense mutations in the bcs1l gene as a cause of the björnstad syndrome. The New England journal of medicine, 356 8:809-19, Feb 2007. URL: https://doi.org/10.1056/nejmoa055262, doi:10.1056/nejmoa055262. This article has 253 citations and is from a highest quality peer-reviewed journal.
(tegelberg2017respiratorychaincomplex pages 1-2): Saara Tegelberg, Nikica Tomašić, Jukka Kallijärvi, Janne Purhonen, Eskil Elmér, Eva Lindberg, David Gisselsson Nord, Maria Soller, Nicole Lesko, Anna Wedell, Helene Bruhn, Christoph Freyer, Henrik Stranneheim, Rolf Wibom, Inger Nennesmo, Anna Wredenberg, Erik A. Eklund, and Vineta Fellman. Respiratory chain complex iii deficiency due to mutated bcs1l: a novel phenotype with encephalomyopathy, partially phenocopied in a bcs1l mutant mouse model. Orphanet Journal of Rare Diseases, Apr 2017. URL: https://doi.org/10.1186/s13023-017-0624-2, doi:10.1186/s13023-017-0624-2. This article has 32 citations and is from a peer-reviewed journal.
(zhan2024conformationsofbcs1l pages 1-2): Jingyu Zhan, Allison R. Zeher, Rick Huang, Wai Kwan Tang, Lisa M. Jenkins, and Di Xia. Conformations of bcs1l undergoing atp hydrolysis suggest a concerted translocation mechanism for folded iron-sulfur protein substrate. Nature Communications, May 2024. URL: https://doi.org/10.1038/s41467-024-49029-y, doi:10.1038/s41467-024-49029-y. This article has 14 citations and is from a highest quality peer-reviewed journal.
(cunatova2024pathologicalvariantsin pages 1-4): Kristýna Čunátová and Erika Fernández‐Vizarra. Pathological variants in nuclear genes causing mitochondrial complex iii deficiency: an update. Journal of Inherited Metabolic Disease, 47:1278-1291, Jul 2024. URL: https://doi.org/10.1002/jimd.12751, doi:10.1002/jimd.12751. This article has 19 citations and is from a peer-reviewed journal.
(cunatova2024pathologicalvariantsin pages 5-7): Kristýna Čunátová and Erika Fernández‐Vizarra. Pathological variants in nuclear genes causing mitochondrial complex iii deficiency: an update. Journal of Inherited Metabolic Disease, 47:1278-1291, Jul 2024. URL: https://doi.org/10.1002/jimd.12751, doi:10.1002/jimd.12751. This article has 19 citations and is from a peer-reviewed journal.
(blazquez2013mitochondrialcomplexiii pages 7-10): Alberto Blázquez, Lorena Marín-Buera, María Morán, Alberto García-Bartolomé, Joaquín Arenas, Miguel A. Martín, and Cristina Ugalde. Mitochondrial complex iii deficiency of nuclear origin. ArXiv, pages 219-238, Sep 2013. URL: https://doi.org/10.1007/978-1-4614-3722-2_14, doi:10.1007/978-1-4614-3722-2_14. This article has 0 citations.
(siddiqi2013novelmutationin pages 1-2): Saima Siddiqi, Saadat Siddiq, Atika Mansoor, Jaap Oostrik, Nafees Ahmad, Syed Ali Raza Kazmi, Hannie Kremer, Raheel Qamar, and Margit Schraders. Novel mutation in aaa domain of bcs1l causing bjornstad syndrome. Journal of Human Genetics, 58:819-821, Oct 2013. URL: https://doi.org/10.1038/jhg.2013.101, doi:10.1038/jhg.2013.101. This article has 26 citations and is from a peer-reviewed journal.
(trinh2021alopeciaandhearing pages 1-2): Ngo Binh Trinh, Hoang Anh Vu, Anh Khoa Pham, Waleed Adawi, Stephanie A. Castillo, and Linh Ngoc Tuong Tran. Alopecia and hearing loss in a boy. Pediatric Dermatology, Nov 2021. URL: https://doi.org/10.1111/pde.14768, doi:10.1111/pde.14768. This article has 1 citations and is from a peer-reviewed journal.
(zhan2024conformationsofbcs1l pages 2-3): Jingyu Zhan, Allison R. Zeher, Rick Huang, Wai Kwan Tang, Lisa M. Jenkins, and Di Xia. Conformations of bcs1l undergoing atp hydrolysis suggest a concerted translocation mechanism for folded iron-sulfur protein substrate. Nature Communications, May 2024. URL: https://doi.org/10.1038/s41467-024-49029-y, doi:10.1038/s41467-024-49029-y. This article has 14 citations and is from a highest quality peer-reviewed journal.
(qurashi2022clinicalanddiagnostic pages 1-2): Mansour Al Qurashi, Ahmed Mustafa, Syed Sameer Aga, Abrar Ahmad, Abdellatif El-Farra, Aiman Shawli, Mohammed Al Hindi, and Mohammed Hasosah. Clinical and diagnostic characteristics of complex iii mitopathy due to novel bcs1l gene mutation in a saudi patient. BMC Medical Genomics, Mar 2022. URL: https://doi.org/10.1186/s12920-022-01210-2, doi:10.1186/s12920-022-01210-2. This article has 3 citations and is from a peer-reviewed journal.
(jackson2016anovelmutation pages 1-2): C. B. Jackson, M. F. Bauer, A. Schaller, U. Kotzaeridou, A. Ferrarini, D. Hahn, H. Chehade, F. Barbey, C. Tran, S. Gallati, A. Haeberli, S. Eggimann, L. Bonafé, and J-M. Nuoffer. A novel mutation in bcs1l associated with deafness, tubulopathy, growth retardation and microcephaly. European Journal of Pediatrics, 175:517-525, Apr 2016. URL: https://doi.org/10.1007/s00431-015-2661-y, doi:10.1007/s00431-015-2661-y. This article has 24 citations and is from a peer-reviewed journal.
(hinson2007missensemutationsin pages 9-10): J. Travis Hinson, Valeria R. Fantin, Jost Schönberger, Noralv Breivik, Geir Siem, Barbara McDonough, Pankaj Sharma, Ivan Keogh, Ricardo Godinho, Felipe Santos, Alfonso Esparza, Yamileth Nicolau, Edgar Selvaag, Bruce H. Cohen, Charles L. Hoppel, Lisbeth Tranebjærg, Roland D. Eavey, J.G. Seidman, and Christine E. Seidman. Missense mutations in the bcs1l gene as a cause of the björnstad syndrome. The New England journal of medicine, 356 8:809-19, Feb 2007. URL: https://doi.org/10.1056/nejmoa055262, doi:10.1056/nejmoa055262. This article has 253 citations and is from a highest quality peer-reviewed journal.
(trinh2021alopeciaandhearing pages 2-2): Ngo Binh Trinh, Hoang Anh Vu, Anh Khoa Pham, Waleed Adawi, Stephanie A. Castillo, and Linh Ngoc Tuong Tran. Alopecia and hearing loss in a boy. Pediatric Dermatology, Nov 2021. URL: https://doi.org/10.1111/pde.14768, doi:10.1111/pde.14768. This article has 1 citations and is from a peer-reviewed journal.
Checked with linkml-reference-validator 0.2.1.
| Outcome | Count |
|---|---|
| References checked | 10 |
| Resolved | 10 |
| Unresolved (possible confabulation) | 0 |
| Unverifiable | 0 |
| References weighed for topical relevance | 10 |
| On topic | 2 |
| Off topic | 0 |
All extracted references resolved successfully.
Checked with linkml-term-validator 0.4.5, through the ols: adapter.
| Outcome | Count |
|---|---|
| Terms checked | 5 |
| Resolved | 3 |
| Unresolved (possible confabulation) | 0 |
| Obsolete | 2 |
| Unverifiable | 0 |
These terms are real but deprecated. Citing one is not a fabrication; it does mean the report is naming something the ontology has retired:
GO:0005750 (obsolete mitochondrial respiratory chain complex III) (2 mentions) - replaced by GO:0045275GO:0070469 (obsolete respirasome) (2 mentions) - replaced by GO:00988033 of 5 terms resolved to a current term; the rest could not be looked up either way.